ClearPoint Neuro, Inc. - 8-K Filing

ClearPoint Neuro reports Q2 revenue of $10.9M, revises full-year guidance to $48–$52M due to regulatory progress and strategic investments (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $CLPT

Read the full article at SEC EDGAR

More Regulatory news